Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

  • February 20, 2024

NET Patient and passionate advocate and fundraiser Rob Hammond shared his story and the plight of NET Patients Australia wide at the Senate Inquiry into “Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer” in Hobart on February 20.

Rob spoke about the challenges around accessing optimal care and the inequities that NET patients face living in Tasmania, including referral pathways, HCP education and low awareness of the disease amongst the general public and healthcare professional community. He touched on the challenges he has faced during this advocacy work and thanked Senator Wendy Askew for the opportunity to speak and feel heard. Thank you Rob for sharing not only your own story, but one that will resonate with so many Tasmanian and NET patients and indeed patients Australia wide. 

Listen to Robs full speech here. 

 

Share this post

Recent posts

Sharon Rickard Completes Run Larapinta 2025!

August 18, 2025

Shane Kent Conquers the World’s Toughest Triathlon for Neuroendocrine Cancer Awareness

August 18, 2025

Turn Your Cans & Bottles into Support for NET Patients

August 12, 2025

National Patient Organisation Network (NPON)

July 24, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNECA presents alongside Peter MacCallum Cancer Centre at the Senate Inquiry
NextTamworth local Ryan Harding advocates for VHL patients to have access to BelzutifanNext

Related Posts

Sharon Rickard Completes Run Larapinta 2025!

A huge congratulations to Sharon Rickard, NET patient and proud CAG Member, who has just conquered the 2025 Run Larapinta Namatjira course — a gruelling

Shane Kent Conquers the World’s Toughest Triathlon for Neuroendocrine Cancer Awareness

What an incredible achievement!  Shane Kent has officially completed the world’s hardest triathlon – the Arch to Arc – in just 57 hours and 37

Turn Your Cans & Bottles into Support for NET Patients

From today, you can help the planet and support people living with neuroendocrine cancer by recycling your cans and bottles! NeuroEndocrine Cancer Australia (NECA) is

National Patient Organisation Network (NPON)

  National Patient Organisation Network (NPON) was held at the Brisbane Convention Centre on Thursday 24 July 2025 which had 50 attendees. Our CEO attended

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin